547 related articles for article (PubMed ID: 21056913)
21. [Dysimmune neuropathies: current diagnosis and therapy].
Léger JM; Larue S; Dashi F
Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
[TBL] [Abstract][Full Text] [Related]
22. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
Linker RA; Gold R
Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
[TBL] [Abstract][Full Text] [Related]
23. Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.
Nobile-Orazio E; Gallia F; Terenghi F; Bianco M
Expert Rev Neurother; 2017 Aug; 17(8):755-765. PubMed ID: 28597710
[TBL] [Abstract][Full Text] [Related]
24. [Immunomodulatory effects of intravenous immunoglobulins].
Kazatchkine M; Mouthon L; Kaveri SV
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy of idiopathic inflammatory neuropathies.
Donofrio PD
Muscle Nerve; 2003 Sep; 28(3):273-92. PubMed ID: 12929187
[TBL] [Abstract][Full Text] [Related]
26. From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve.
Meyer zu Hörste G; Hartung HP; Kieseier BC
Nat Clin Pract Neurol; 2007 Apr; 3(4):198-211. PubMed ID: 17410107
[TBL] [Abstract][Full Text] [Related]
27. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
Gold R; Stangel M; Dalakas MC
Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
29. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
30. Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins.
Trebst C; Brunhorn K; Lindner M; Windhagen A; Stangel M
Eur J Neurol; 2006 Dec; 13(12):1359-63. PubMed ID: 17116220
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and management of immune-mediated neuropathies].
Hsieh ST
Acta Neurol Taiwan; 2004 Mar; 13(1):39-45. PubMed ID: 15315301
[TBL] [Abstract][Full Text] [Related]
32. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
33. What's new in multifocal motor neuropathy in 2007-2008?
Nobile-Orazio E
J Peripher Nerv Syst; 2008 Dec; 13(4):261-3. PubMed ID: 19192064
[TBL] [Abstract][Full Text] [Related]
34. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
Soueidan SA; Dalakas MC
Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
[TBL] [Abstract][Full Text] [Related]
35. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
[TBL] [Abstract][Full Text] [Related]
36. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
37. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
Rütter A; Luger TA
J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
Comi G; Quattrini A; Fazio R; Roveri L
Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
[TBL] [Abstract][Full Text] [Related]
39. Update on therapy of chronic immune-mediated neuropathies.
Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
[TBL] [Abstract][Full Text] [Related]
40. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
Hidou M; Olivier J; Vivant JF
Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
